Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca India receives CDSCO approval for Durvalumab in combination with FLOT chemotherapy
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, announces the Central Drugs Standard Control…
Rx-to-OTC is not a channel shift—it’s a complete business model shift
By 2030, what will truly differentiate winning OTC players in India from the rest?
By 2030, the biggest differentiator for…
Uttar Pradesh gears up to showcase pharma investment opportunities at Pharma Conclave 1.0
The Uttar Pradesh Food Safety and Drug Administration (FSDA) and Invest UP will co-host “Pharma Conclave 1.0: Investment…
Lupin and TB Alliance collaborate to advance Telacebec for treatment of TB and other mycobacterial…
Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to advance the clinical development and…
India-EU FTA offers new hope
The signing of the India-EU Free Trade Agreement after almost two decades of negotiations is being hailed as the ‘mother of all…
Industry calls Union Budget 2026 a defining moment for India’s biopharma future
Industry stakeholders view the Union Budget 2026 as a pivotal inflection point in India’s life sciences journey. With the launch…
Biopharma gets a boost in Budget 2026 with ₹10,000-crore outlay
Biopharma Shakti programme to boost domestic manufacturing of biologics and biosimilars. The Budget also announces customs duty…
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero
How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…
What It Takes to Build Pharmaceutical Facilities That Perform from Day One
The pharmaceutical facility landscape has become increasingly complex. Regulatory expectations, operational efficiency,…
Local focus to strengthen Indian pharmaceutical manufacturers
Why is localising format part production an important step for Indian pharmaceutical companies and Romaco?
Sanjeev Nimkar: It…